Researchers quantify the economic damage caused by climate-change-related heat stress on the global workforce.

14 October, 1:00 pm

And what we need to focus on next

When Starmer’s government cut 40 per cent from the international aid budget, it presumably did not intend to shred scientific research

Greater access to satellite systems means the continent can now utilise more data than ever

Vilija Vėlyvytė argues that the UK-US medicines deal which will see the NHS pay more for new medicines is an unexpected cost of Brexit.

The answer is obvious to all except the real climate change zealots: the anti-net zero movement

Nigeria's solar expansion relies heavily on lead-acid batteries that typically fail within a few years. Yet nobody can say with confidence where most are recycled or disposed of. ETA Analysis…

For the first time in the UK, more new electric vehicles (EVs) have been sold over a 12-month period than petrol cars, according to Carbon Brief analysis.

Report argues that switching to heat pumps and electric cars would bring down energy bills and avoid price shocks

The U.S. and pharma companies are increasing the pressure on EU countries to pay more for medicines.

Sir Pascal Soriot says countries will have to spend more on innovative medicines following US trade deal

Investigations suggest that, in some fields, at least one-quarter of clinical trials might be problematic or even entirely made up, warn some researchers. They urge stronger scrutiny.

Health secretary’s ‘power grab’ to override Nice comes amid growing concern move may be illegal and benefit big pharma

G overnments around the world are cutting taxes on petrol or fuel, including in Germany, Italy, Spain and Canada. The UK government has c...

Top models including OpenAI and DeepSeek make judgments too quickly when patient data is incomplete

Financing Common Goods for Health, sponsored by the World Health Organization, Department of Health Systems Governance and Financing. Volume 5, Issue 4 of Health Systems & Reform

Shadow prices are value estimates of capital assets, goods and services that include the value of externalities associated with them. In other words, they aim to capture the social worth of...

Ministers will be given the power to control NHS drug approvals despite warnings it could lead to political interference in decisions about funding new treatments. Proposals to allow ministers to cha...

There has been considerable hype about the transformative potential of AI across many domains of society. Hetan will consider the promise and pitfalls of AI in health, and how we should think about

When I write about fiscal watchdogs like the OBR in the UK, I generally get some comments along the lines that these watchdogs produce tec...

The UK cost-per-QALY threshold remains a pivotal component of health technology assessment (HTA). Yet its meaning, credibility, and operational role are increasingly contested. The threshold is often

Giving ministers more power over NHS drug pricing could reshape how public money is spent on health.

A new study from the Sheffield Addictions Research Group (SARG) has found that public health policies which reduce spending on harmful products can actually provide a significant boost to UK jobs and ...

Climate and nature can no longer be pigeonholed as an environmental problem.

A large fraction of cancers are linked to two modifiable habits: tobacco smoking and alcohol consumption.

How should health be valued in UK #PolicyEvaluation?🩺 As the NICE - National Institute for Health and Care Excellence cost-per-QALY threshold faces increasing scrutiny and political pressures, the de...

Why regulators work for the companies they oversee, and what to do about it.